metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology P-7 EPIDEMIOLOGY OF AUTOIMMUNE HEPATITIS IN LATIN AMERICA: PRELIMINARY RESULTS F...
Journal Information
Vol. 29. Issue S3.
Abstracts of the 2023 Annual Meeting of the ALEH
(December 2024)
Share
Share
Download PDF
More article options
Vol. 29. Issue S3.
Abstracts of the 2023 Annual Meeting of the ALEH
(December 2024)
Full text access
P-7 EPIDEMIOLOGY OF AUTOIMMUNE HEPATITIS IN LATIN AMERICA: PRELIMINARY RESULTS FROM ALLATIN COHORT
Visits
11
Guilherme Grossi Lopes Cançado1, Ludmila Resende Guedes1, Ezequiel Ridruejo2, Lorena Castro Solari3, Debora Raquel Benedita Terrabuio4, Emilia Vera5, Harlim Rodríguez6, Pablo Andres Coste Murillo7, Janaína Luz Narciso Schiavon8, Álvaro Urzúa9, Carlos Benítez Gajardo10, Eira Cerda Reyes11, Artur Maia de Castro Miranda1, Paulo Lisboa Bittencourt12, Mario Guimarães Pessoa4, Maria Lucia Ferraz13, Cristiane Alves Villela-Nogueira14, Eduardo Luiz Rachid Cançado4, Claudia Alves Couto1
1 Universidade Federal de Minas Gerais, Belo Horizonte, Brasil
2 Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno, Buenos Aires, Argentina
3 Clinica Universidad de los Andes, Santiago, Chile
4 Universidade de São Paulo, São Paulo, Brasil
5 Hospital Regional Guayaquil, Guayaquil, Ecuador
6 Instituto de Gastroenterología de Cuba, Habana, Cuba
7 Hospital R. A. Calderón Guardia, San José, Costa Rica
8 Universidade Federal de Santa Catarina, Florianópolis, Brasil
9 Universidad de Chile, Santiago, Chile
10 UC Christus, Santiago, Chile
11 Hospital Central Militar México, Ciudad de México, México
12 Hospital Portugues, Salvador, Brasil
13 Universidade Federal de São Paulo, São Paulo, Brasil
14 Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brasil
Ver más
This item has received
Article information
Special issue
This article is part of special issue:
Vol. 29. Issue S3

Abstracts of the 2023 Annual Meeting of the ALEH

More info
Conflict of interest

No

Introduction and Objectives

Autoimmune hepatitis (AIH) is a rare disease characterized by a destructive immune response to hepatocytes in the absence of an identified causative agent. The epidemiology of AIH in Latin America is largely unknown. This study aims to address the epidemiology of AIH in Latin America.

Patients / Materials and Methods

This ongoing retrospective, international, multicentric cohort study, sponsored by ALEH, enrolls AIH patients from different countries in Latin America.

Results and Discussion

Data were accrued on 200 patients [Brazil (36.3%), Argentina (22.3%), Chile (21.8%), Cuba (7.3%), Costa Rica (5.2%), Ecuador (5.2%), and Mexico (2.1%)], 85.9% female, with a mean age at AIH diagnosis of 43.8 years. The most common form of disease presentation was chronic asymptomatic elevation of liver enzymes (40.9%), while acute severe hepatitis and fulminant hepatitis were observed in 7.2% and 2.8% of cases, respectively. Cirrhosis was present in 39% of patients at diagnosis. AIH type 1 was diagnosed in 93.7%, type 2 in 1.6%, while 4.8% were seronegative. Overlap with primary biliary cholangitis and primary sclerosing cholangitis was reported in 5.7% and 2.9% of cases, respectively. Most patients were symptomatic (66.8%) at diagnosis, with jaundice (42.4%) and asthenia (28.3%) being the main symptoms. Hashimoto thyroiditis (11.4%) and lupus (4.9%) were the most common extrahepatic autoimmune diseases associated with AIH. Prednisone was prescribed to 86%, azathioprine to 81%, and mycophenolate to 8% of patients as first-line treatments. Complete biochemical response after the first 12 months of treatment was achieved by 66.9% of patients. Mycophenolate (60%) was the preferred option for second-line therapy, which was prescribed to 10.7% of the individuals. Of the patients, 10.5% died, while 1.5% underwent liver transplantation. Hepatocellular carcinoma was diagnosed in 1.1% of patients.

Conclusions

Our unprecedented data shed light on AIH epidemiology and management in Latin America.

Full text is only aviable in PDF
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos